Nav: Home

New US recommendation for diabetes screening may miss ethnic minority groups

July 12, 2016

In response to the worldwide diabetes epidemic, many countries are focusing healthcare efforts in order to improve evidence-based diabetes prevention and treatments. In 2015, the United States Preventive Services Task Force (USPSTF), an independent group of clinical experts whose work is supported by the U.S. government, issued a new recommendation to screen adults aged 40-70 years old who are overweight or obese for dysglycemia (a term used to describe those with either diabetes or prediabetes). In a study published in PLOS Medicine, as part of the Preventing Diabetes special issue which is Guest Edited by Professors Nick Wareham and William Herman, Matthew O'Brien (Northwestern University, USA) and colleagues present the results of their cohort analysis to determine the effectiveness of this screening program. Surprisingly, they show that this approach may only detect half of adults with undiagnosed dysglycemia; worryingly, this detection rate drops for racial or and ethnic minorities, compared to whites.

The authors conducted a retrospective analysis of electronic health records for 50,515 adult patients receiving primary care in 6 large community health centres in the Midwest and Southwest. Only 12,679 of the patients actually fulfilled the USPSTF criteria for screening. The authors show that of the 29,946 patients who completed a screening test within the three-year follow up period, 8,478 developed dysglycemia. Only 45% of these patients with dysglycemia would have been identified by the new USPSTF criteria. In addition, dysglycemia is less likely to be identified in minority patients. Among those who developed dysglycemia, the screening criteria detected 54.5% of whites, compared to 50.3% of Blacks and 37.7% of Hispanic/Latino patients. This difference reflects that more patients within these groups develop dysglycemia at a normal weight or aged under 40, relative to whites.

By reporting on the limited effectiveness of this screening program, this study raises concerns about the program's broad utility, particularly among racial and ethnic minority groups. Primary care providers may need to consider screening minority patients who are younger than 40 years old and have a normal weight. There may be economic consequences as health insurance providers may decide not to fund screening outside of this USPSTF recommendation, which could pass the full cost of testing onto patients.
-end-
Research Article

Funding:

We acknowledge the funders of this study: the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health (K23DK095981; http://www.niddk.nih.gov/; MJO), the Agency for Healthcare Research and Quality (P01HS21141; http://www.ahrq.gov/), and the Chicago Center for Diabetes Translation Research (P30DK092949; http://chicagodiabetesresearch.org/pilot-and-feasibility-grants/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing Interests:

The authors have declared that no competing interests exist.

Citation:

O'Brien MJ, Lee JY, Carnethon MR, Ackermann RT, Vargas MC, Hamilton A, et al. (2016) Detecting Dysglycemia Using the 2015 United States Preventive Services Task Force Screening Criteria: A Cohort Analysis of Community Health Center Patients. PLoS Med 13(7): e1002074. doi:10.1371/journal.pmed.1002074

Author Affiliations:

Division of General Internal Medicine and Geriatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America
Center for Community Health, Institute for Public Health and Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America
Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America
Alliance of Chicago Community Health Services, L3C, Chicago, Illinois, United States of America
Erie Family Health Center, Chicago, Illinois, United States of America
Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States of America
Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, United States of America

IN YOUR COVERAGE PLEASE USE THIS URL TO PROVIDE ACCESS TO THE FREELY AVAILABLE PAPER:

http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1002074

Contact

Matthew O'Brien
Assistant Professor of Medicine
Northwestern University
Feinberg School of Medicine
750 N. Lake Shore Drive
Chicago, IL 60611
UNITED STATES
312-503-5046
matthew.obrien1@northwestern.edu

PLOS

Related Diabetes Articles:

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).
Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.
People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.
Diabetes, but not diabetes drug, linked to poor pregnancy outcomes
New research indicates that pregnant women with pre-gestational diabetes who take metformin are at a higher risk for adverse pregnancy outcomes -- such as major birth defects and pregnancy loss -- than the general population, but their increased risk is not due to metformin but diabetes.
New oral diabetes drug shows promise in phase 3 trial for patients with type 1 diabetes
A University of Colorado Anschutz Medical Campus study finds sotagliflozin helps control glucose and reduces the need for insulin in patients with type 1 diabetes.
More Diabetes News and Diabetes Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Erasing The Stigma
Many of us either cope with mental illness or know someone who does. But we still have a hard time talking about it. This hour, TED speakers explore ways to push past — and even erase — the stigma. Guests include musician and comedian Jordan Raskopoulos, neuroscientist and psychiatrist Thomas Insel, psychiatrist Dixon Chibanda, anxiety and depression researcher Olivia Remes, and entrepreneur Sangu Delle.
Now Playing: Science for the People

#537 Science Journalism, Hold the Hype
Everyone's seen a piece of science getting over-exaggerated in the media. Most people would be quick to blame journalists and big media for getting in wrong. In many cases, you'd be right. But there's other sources of hype in science journalism. and one of them can be found in the humble, and little-known press release. We're talking with Chris Chambers about doing science about science journalism, and where the hype creeps in. Related links: The association between exaggeration in health related science news and academic press releases: retrospective observational study Claims of causality in health news: a randomised trial This...